|
COX11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.24749999009089E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.38049999992762E-07 |
| Normal-vs-Stage2 |
2.264200E-01 |
| Normal-vs-Stage3 |
2.30819996449583E-09 |
| Normal-vs-Stage4 |
4.822597876597E-11 |
| Stage1-vs-Stage2 |
2.299200E-03 |
| Stage1-vs-Stage3 |
9.358200E-02 |
| Stage1-vs-Stage4 |
5.544100E-03 |
| Stage2-vs-Stage3 |
1.399200E-04 |
| Stage2-vs-Stage4 |
2.07339999999112E-05 |
| Stage3-vs-Stage4 |
1.459380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.60120053169533E-10 |
| Normal-vs-AfricanAmerican |
1.602070E-02 |
| Normal-vs-Asian |
3.040100E-04 |
| Caucasian-vs-AfricanAmerican |
2.863400E-01 |
| Caucasian-vs-Asian |
3.253200E-01 |
| AfricanAmerican-vs-Asian |
8.093600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.20269996581624E-09 |
| Normal-vs-Female |
3.38869999838565E-08 |
| Male-vs-Female |
1.750830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04159999958497E-07 |
| Normal-vs-Age(41-60Yrs) |
2.03159999934144E-08 |
| Normal-vs-Age(61-80Yrs) |
2.11490000001646E-06 |
| Normal-vs-Age(81-100Yrs) |
8.324000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.717200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.896800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.200400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.629600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.061400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.046600E-04 |
| Classical-VS-Follicular |
4.40449999999926E-05 |
| Classical-VS-Other |
8.299600E-01 |
| Classical-VS-Normal |
5.50900003393195E-09 |
| Tall-VS-Follicular |
8.45640002467007E-09 |
| Tall-VS-Other |
1.618850E-01 |
| Tall-VS-Normal |
6.41542374779647E-12 |
| Follicular-VS-Other |
1.370360E-01 |
| Follicular-VS-Normal |
1.547390E-01 |
| Other-VS-Normal |
7.516500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32099999999402E-05 |
| Normal-vs-N1 |
6.44639897018351E-11 |
| N0-vs-N1 |
1.246870E-04 |
|
|
